FI900017L - Menetelmä tehoainetta alhaisen annoksen kontrolloidusti vapauttavien aspiriinitablettien valmistamiseksi - Google Patents
Menetelmä tehoainetta alhaisen annoksen kontrolloidusti vapauttavien aspiriinitablettien valmistamiseksi Download PDFInfo
- Publication number
- FI900017L FI900017L FI900017A FI900017A FI900017L FI 900017 L FI900017 L FI 900017L FI 900017 A FI900017 A FI 900017A FI 900017 A FI900017 A FI 900017A FI 900017 L FI900017 L FI 900017L
- Authority
- FI
- Finland
- Prior art keywords
- active ingredient
- controlled release
- low dose
- aspirin tablets
- preparing aspirin
- Prior art date
Links
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 title 1
- 229960001138 acetylsalicylic acid Drugs 0.000 title 1
- 239000004480 active ingredient Substances 0.000 title 1
- 238000013270 controlled release Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/293,832 US4970081A (en) | 1989-01-03 | 1989-01-03 | Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith |
| US29383289 | 1989-01-03 | ||
| US42662089A | 1989-10-24 | 1989-10-24 | |
| US42662089 | 1989-10-24 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI900017A0 FI900017A0 (fi) | 1990-01-03 |
| FI900017L true FI900017L (fi) | 1990-07-04 |
| FI95776B FI95776B (fi) | 1995-12-15 |
| FI95776C FI95776C (fi) | 1996-03-25 |
Family
ID=26968181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI900017A FI95776C (fi) | 1989-01-03 | 1990-01-03 | Menetelmä tehoainetta alhaisen annoksen kontrolloidusti vapauttavien aspiriinitablettien valmistamiseksi |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0377439B1 (fi) |
| JP (1) | JP2966871B2 (fi) |
| KR (1) | KR0151590B1 (fi) |
| AR (1) | AR244548A1 (fi) |
| AT (1) | ATE127690T1 (fi) |
| AU (1) | AU622254B2 (fi) |
| CA (1) | CA2006975C (fi) |
| DE (1) | DE69022251T2 (fi) |
| DK (1) | DK0377439T3 (fi) |
| ES (1) | ES2076975T3 (fi) |
| FI (1) | FI95776C (fi) |
| GR (1) | GR3017576T3 (fi) |
| HK (1) | HK35396A (fi) |
| IE (1) | IE69270B1 (fi) |
| IL (1) | IL92854A (fi) |
| MX (1) | MX174376B (fi) |
| MY (1) | MY104871A (fi) |
| NO (1) | NO177127C (fi) |
| NZ (1) | NZ231954A (fi) |
| PT (1) | PT92780B (fi) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5851579A (en) * | 1996-10-28 | 1998-12-22 | Eastman Chemical Company | Aqueous enteric coating compositions |
| BR9810027A (pt) * | 1997-06-11 | 2000-09-12 | Procter & Gamble | Comprimido revestido por pelìcula para melhorada segurança do trato gastrintestinal superior |
| KR20070093988A (ko) * | 2005-01-06 | 2007-09-19 | 씨브이 쎄러퓨틱스, 인코포레이티드 | 라놀라진 함유 서방성 약제학적 제형물 |
| WO2008140459A1 (en) * | 2007-05-16 | 2008-11-20 | Fmc Corporation | Solid form |
| KR101109633B1 (ko) * | 2007-08-03 | 2012-01-31 | 제이더블유중외제약 주식회사 | 활성성분의 코팅막이 보호되는 구강내붕해제형을 제조하기위한 조성물 |
| WO2017062027A1 (en) * | 2015-10-09 | 2017-04-13 | Bayer Healthcare Llc | Modified release formulation of naproxen sodium |
| JP7219623B2 (ja) * | 2018-01-30 | 2023-02-08 | 日東電工株式会社 | 経皮吸収型製剤 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3264867D1 (en) * | 1981-04-27 | 1985-08-29 | Haessle Ab | New pharmaceutical preparation |
| GB8519310D0 (en) * | 1985-07-31 | 1985-09-04 | Zyma Sa | Granular active substances |
| GB8521494D0 (en) * | 1985-08-29 | 1985-10-02 | Zyma Sa | Controlled release tablet |
| NZ228557A (en) * | 1988-04-05 | 1990-11-27 | Kyowa Hakko Kogyo Kk | Coating agent for delaying the release of active agents to be administered per os to ruminants, and veterinary compositions |
| US4866046A (en) * | 1988-05-31 | 1989-09-12 | Top Laboratories, Inc. | Low-dosage sublingual aspirin |
-
1989
- 1989-12-20 AU AU47194/89A patent/AU622254B2/en not_active Expired
- 1989-12-20 IE IE412089A patent/IE69270B1/en not_active IP Right Cessation
- 1989-12-21 NZ NZ231954A patent/NZ231954A/en unknown
- 1989-12-22 IL IL9285489A patent/IL92854A/en not_active IP Right Cessation
- 1989-12-22 MX MX1888389A patent/MX174376B/es unknown
-
1990
- 1990-01-02 EP EP90100032A patent/EP0377439B1/en not_active Expired - Lifetime
- 1990-01-02 CA CA002006975A patent/CA2006975C/en not_active Expired - Lifetime
- 1990-01-02 DK DK90100032.3T patent/DK0377439T3/da active
- 1990-01-02 DE DE69022251T patent/DE69022251T2/de not_active Expired - Lifetime
- 1990-01-02 NO NO900009A patent/NO177127C/no not_active IP Right Cessation
- 1990-01-02 ES ES90100032T patent/ES2076975T3/es not_active Expired - Lifetime
- 1990-01-02 AT AT90100032T patent/ATE127690T1/de not_active IP Right Cessation
- 1990-01-03 PT PT92780A patent/PT92780B/pt not_active IP Right Cessation
- 1990-01-03 FI FI900017A patent/FI95776C/fi active IP Right Grant
- 1990-01-03 AR AR90315876A patent/AR244548A1/es active
- 1990-01-03 KR KR1019900000044A patent/KR0151590B1/ko not_active Expired - Fee Related
- 1990-01-03 MY MYPI90000004A patent/MY104871A/en unknown
- 1990-01-04 JP JP2000198A patent/JP2966871B2/ja not_active Expired - Lifetime
-
1995
- 1995-09-29 GR GR950402381T patent/GR3017576T3/el unknown
-
1996
- 1996-02-29 HK HK35396A patent/HK35396A/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI930657A7 (fi) | Menetelmä pidennetyn aktiiviaineluovutuksen omaavien annosmuotojen valmistamiseksi | |
| FI885101L (fi) | Menetelmä lääkettä säännöstellysti vapauttavan annostusmuodon valmistamiseksi | |
| HUT47843A (en) | Process for producing pharmaceutical with regulated active ingredient release | |
| IT8820145A0 (it) | Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione. | |
| FI921104A7 (fi) | Istutettava vapautuslääkkeenjakaja | |
| EP0224146A3 (en) | Pharmaceutical preparation for the controlled release of active ingredients | |
| FI885460L (fi) | Menetelmä suun kautta annettavaksi tarkoitetun, aktiiviyhdistettä kontrolloidusti vapauttavan farmaseuttisen formulaation valmistamiseksi | |
| DE3880593D1 (de) | Arzneizubereitungen mit retardierter wirkstofffreisetzung. | |
| DK362189D0 (da) | Farmaceutisk praeparat til intravenoes indgift | |
| MX17752A (es) | Formulaciones farmaceuticas y procedimiento para prepararlas | |
| HUT45186A (en) | Insecticides comprising heterocyclic compounds as active ingredient and process for producing the active ingredient | |
| ZA894020B (en) | Controlled release pharmaceutical formulation | |
| IL70071A (en) | Multilayered sustained release pharmaceutical tablets having non-uniform distribution of active ingredient | |
| DE68909772D1 (de) | Diclofenac-Natrium-Arzneizubereitung mit verlängerter Wirkstoffabgabe. | |
| GB2187643B (en) | Method for the preparation of tablets slowly releasing the active principle | |
| HUT49625A (en) | Process for producing macrolid compounds and pharmaceutical compositions comprising such active ingredient | |
| DE59003337D1 (de) | Pressling mit retardierter Wirkstofffreisetzung. | |
| DK256290A (da) | Farmaceutisk praeparat indeholdende deoxyribonucleosider til saarheling | |
| GB2226804B (en) | Process for preparing microcapsules providing the rapid release of a drug as active ingredient | |
| NO173239C (no) | Analogifremgangsmaate til fremstilling av et terapeutisk aktivt etopodofyllotoksinglukosidacylderivat | |
| NO883500D0 (no) | Fremgangsmaate for fremstilling av et farmasoeytisk aktivt nitrometan. | |
| FI913409L (fi) | Menetelmä vaikuttavana aineena mesnaa sisältävien tablettien ja granulaatin valmistamiseksi | |
| FI900017L (fi) | Menetelmä tehoainetta alhaisen annoksen kontrolloidusti vapauttavien aspiriinitablettien valmistamiseksi | |
| HUT47233A (en) | Process for producing pharmaceutical comprising phenol derivatives as active ingredient and for producing the active ingredients | |
| FI891069A7 (fi) | Suun kautta annettava järjestelmä vaikuttavan aineen säädettyä vapautumista varten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC | Name/ company changed in application |
Owner name: STERLING WINTHROP INC. |
|
| BB | Publication of examined application | ||
| FG | Patent granted |
Owner name: STERLING WINTHROP INC. |